Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|April 23, 2020
Mitochondrial Protection by PARP InhibitionFerenc Gallyas, Balazs Sumegi
Cancers|February 29, 2020
Role of Akt Activation in PARP Inhibitor Resistance in CancerFerenc Gallyas, Balazs Sumegi, Csaba Szabo
Biochemical Pharmacology|March 29, 2003
Concentration dependent mitochondrial effect of amiodaroneGabor Varbiro, Ambrus Toth, Antal Tapodi, et al.
BMC Cancer|December 25, 2007
Correlation between the progressive cytoplasmic expression of a novel small heat shock protein (Hsp16.2) and malignancy in brain tumorsEva Pozsgai, Eva Gomori, Andras Szigeti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2004
Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in miceBalazs Veres, Balazs Radnai, Ferenc Gallyas, et al.
European Journal of Cell Biology|September 1, 2009
Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cellsArpad Boronkai, Szabolcs Bellyei, Andras Szigeti, et al.
Journal of Cancer|April 16, 2015
Role of mitochondrial network stabilisation by a human small heat shock protein in tumour malignancyZsuzsanna Turi, Eniko Hocsak, Boglarka Racz, et al.
Biochemical Pharmacology|December 13, 2005
Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusionKrisztina Kovacs, Ambrus Toth, Peter Deres, et al.
Molecular and Cellular Biochemistry|February 22, 2012
BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinasesZsolt Sarszegi, Eszter Bognar, Balazs Gaszner, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2003
Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transitionGabor Varbiro, Ambrus Toth, Antal Tapodi, et al.
Pageof 13